Health Care: Drugs

Navidea Biopharmaceuticals Inc (NAVB: AMEX)

$1.71 0.01 | 0.59%
08/04/15 - 02:34 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 6.27M 1.13M 78.74K 597.73K
Cost of Sales 241.71K 332.82K 0.00 0.00
Gross Operating Profit 6.03M 797.82K 78.74K 597.73K
Selling, General, and Administrative Expenses 15.54M 15.53M 11.18M 9.55M
Research & Development 16.78M 23.71M 16.89M 15.15M
Operating Income before D & A (EBITDA) -26.29M -38.44M -27.99M -24.10M
Depreciation & Amortization 1.34M 1.17M 744.74K 180.35K
Interest Income 16.10K 18.84K 25.04K 25.76K
Other Income - Net -3.88M -1.50M -26.61K -955.59K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -32.02M -41.09M -28.74M -25.21M
Interest Expense 3.71M 2.78M 1.17M 13.33K
Pre-Tax Income -35.73M -43.87M -29.90M -25.23M
Income Taxes 0.00 0.00 0.00 -7.88M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -35.73M -42.70M -29.16M -17.17M
Net Income From Discontinued Operations 0.00 0.00 0.00 22.78M
Net Income From Total Operations -35.73M -42.70M -29.16M 5.61M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -35.73M -42.70M -29.16M 5.61M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-35.73M -42.70M -29.16M -17.17M
Preferred Dividends
Net Income Available To Common -35.73M -42.70M -29.20M -17.27M
Basic EPS from Continuing Ops. -0.24 -0.35 -0.29 -0.17
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.23
Basic EPS from Total Operations -0.24 -0.35 -0.29 0.06
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.24 -0.35 -0.29 0.06
Basic Normalized Net Income/Share -0.24 -0.35 -0.29 -0.17
EPS fr Continuing Ops. -0.24 -0.35 -0.29 -0.19
EPS fr Discontinued Ops 0.00 0.00 0.00 0.23
EPS fr Total Ops. -0.24 -0.35 -0.29 0.04
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.02
EPS, Total -0.24 -0.35 -0.29 0.06
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.24 -0.35 -0.29 -0.19
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NAVB

Latest NAVB Headlines from TheStreet

More Financial News for NAVB

Press Releases for NAVB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter